CervoMed (CRVO) Change in Acquisitions & Divestments (2015 - 2026)
CervoMed (CRVO) posted Change in Acquisitions & Divestments of $8.7 million for Q1 2026, down 13.0% sequentially from $10.0 million in Q4 2025, and down 30.4% YoY from $12.5 million in Q1 2025.
CervoMed (CRVO) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends
CervoMed has reported Change in Acquisitions & Divestments for 6 years, with the latest figure at $8.7 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 30.4% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.7 million (up 24.3% YoY) and the FY2025 annual result came in at $43.5 million, up 123.77% from the prior year.
- Change in Acquisitions & Divestments fell to $8.7 million in Q1 2026 per CRVO's latest filing, from $10.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $12.9 million in Q4 2024 and troughed at -$12.5 million in Q3 2023.
- A 5-year average of $7.5 million and a median of $9.5 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments tumbled 228.21% in 2023, then surged 152.0% in 2024.
- Over 5 years, Change in Acquisitions & Divestments stood at $7.0 million in 2022, then slumped by 278.57% to -$12.5 million in 2023, then soared by 203.52% to $12.9 million in 2024, then decreased by 22.72% to $10.0 million in 2025, then decreased by 13.0% to $8.7 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $8.7 million, $10.0 million, and $11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.00 Mn |
| Jun 30, 2026 | 5.00 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Dec 31, 2024 | 12.94 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Sep 30, 2024 | 6.50 Mn |
| Sep 30, 2023 | -12.50 Mn |
| Sep 30, 2023 | -12.50 Mn |
| Jun 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 3.00 Mn |